Literature DB >> 20019756

Atrial fibrillation: A promising new anticoagulant for stroke prevention.

Sarah A Spinler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20019756     DOI: 10.1038/nrcardio.2009.220

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  6 in total

Review 1.  Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.

Authors:  Brooke E Baetz; Sarah A Spinler
Journal:  Pharmacotherapy       Date:  2008-11       Impact factor: 4.705

Review 2.  Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Mark N Levine; Gary Raskob; Rebecca J Beyth; Clive Kearon; Sam Schulman
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

3.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

4.  Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran.

Authors:  Michael D Ezekowitz; Stuart Connolly; Amit Parekh; Paul A Reilly; Jeanne Varrone; Susan Wang; Jonas Oldgren; Ellison Themeles; Lars Wallentin; Salim Yusuf
Journal:  Am Heart J       Date:  2009-05       Impact factor: 4.749

5.  Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States.

Authors:  William L Baker; Deborah A Cios; Stephen D Sander; Craig I Coleman
Journal:  J Manag Care Pharm       Date:  2009-04

6.  Effect of clopidogrel added to aspirin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Janice Pogue; Robert G Hart; Stefan H Hohnloser; Marc Pfeffer; Susan Chrolavicius; Salim Yusuf
Journal:  N Engl J Med       Date:  2009-03-31       Impact factor: 91.245

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.